期刊文献+

左乙拉西坦预防动物热性惊厥的实验研究 被引量:9

Study on Prophylaxis of Febrile Convulsion with Levetiracetam in Rats
在线阅读 下载PDF
导出
摘要 目的:观察左乙拉西坦预防动物热性惊厥发作的疗效与毒副反应。方法:60只对热惊厥敏感的Wistar大鼠,随机分为四组,实验组分别按100、200、300mg/(k.d)的剂量灌服左乙拉西坦,对照组予生理盐水,5d后观察其热性惊厥敏感性改变情况和毒副反应。结果:Wistar大鼠用药后,在热水浴中发生惊厥的潜伏期分别从(243.8±35.2)s、(231.3±43.9)s、(223.4±48.2)s延长到(262.2±32.8)s、(301.8±56.9)s、(303.8±55.3)s;惊厥持续时间分别从(151.2±71.9)s、(131.3±58.1)s、(146.4±51.6)s缩短到(120.8±46.8)s、(77.7±53.2)s、(55.2±28.7)s;热惊厥发生程度也明显减轻,除低剂量组外,中剂量组和高剂量组与对照组比较差异有统计学意义(t=4.32~18.5,P<0.05或P<0.01)。不良反应表现轻微,血常规和肝肾功能均无异常改变。结论:左乙拉西坦具有预防动物热性惊厥的作用。 Objective:To observe the prophylactic effect and side effects of monotherapy of levetiracetam (LEV) on febrile seizure in rats. Methods: Sixty Wistar rats were equally randomized into four groups and were administered physiologic saline, LEV 100, 200, 300 mg/kg per day by a gastric tube for 5 days. The susceptiveness to hot bath after treated with LEV and the side effects were observed. Results: The latent period of seizure of rats exposed to hot bath and treated with LEV was significantly delayed, from (243.8 ± 35.2) s, (231.3 ± 43.9) s and (223.4 ± 48.2) s to (262.2± 32.8) s, ( 301.8 ± 56.9) s and ( 303.8 ± 55.3 ) s. Even if seizure occurred, the lasting time was apparently less, namely from ( 151.2 ± 71.9) s, ( 131.3± 58.1 ) s and ( 146.4 ± 51.6) s to ( 120.8 ± 46.8 ) s, (77.7 ±53.2) s and (55.2± 28.7)s. There were significant differences between the control group and the mid dose group and the high dose group. The degree of seizure was also reduced. The side effect was slight. The hematological examination and the liver and kidney function were normal. Conclusions: Levetiracetam can efficiently prevent febrile seizure in rats.
出处 《儿科药学杂志》 CAS 2009年第4期16-18,共3页 Journal of Pediatric Pharmacy
关键词 左乙拉西坦 热性惊厥 预防 Levetiracetam Febrile seizure Prevention
  • 相关文献

参考文献3

二级参考文献9

共引文献8

同被引文献68

  • 1朱乾乾,王丽君,吕娟,郝云鹏,陈银波,梁东.左乙拉西坦预防儿童热性惊厥的临床研究及随访[J].环球中医药,2013,6(S2):105-106. 被引量:7
  • 2黄志,李娟.三种抗惊厥药物预防动物热性惊厥的比较研究[J].华南国防医学杂志,2006,20(2):12-14. 被引量:2
  • 3徐惠琴,朱遂强,郑荣远,王开颜,李安乐,杨学志.托吡酯对戊四氮点燃慢性癫大鼠海马神经细胞黏附分子的影响[J].中国临床神经科学,2006,14(5):491-493. 被引量:3
  • 4Jiang W, Duong TM, Lanerolle NC. The neuropathology of hyperthermic seizures in the rats[J]. Epilepsia, 1999, 40(1 ) :5-19.
  • 5Patsalos PN. Pharmacokinetic profile of levetiracetam : toward ideal characteristics [ J]. Pharmacol Ther, 2000, 85 (2):77-85.
  • 6Tong X, Patsalos PN. A microdialysis study of the novel antiepileptic drug levetiracetam: extracellular pharmacokinetics and effect on taurine in rat brain [J]. Br J Pharmacol, 2001 , 133(6) :867- 874.
  • 7Brockmoller J, Thomsen T, Wittstock M, Coupez R, Lochs H, Roots I. Pharmacokinetics of levitiracetam in patients with moderate to severe liver cirrhosis ( Child-Pugh classes A. B and C ) : characterization by dynamic liver function tests [J]. Clin Pharmacol Ther, 2005, 77 ( 6 ) :529-541.
  • 8Zona C, Niespodziany I, Marchetti C, Klitgaard H, Bernardi G, Margineanu DG. Levitiracetam does not modulate neuronal voltagegated Na^+ and T-type Ca^2+ currents [J]. Seizure, 2001, 10 (4) :279-286.
  • 9Klitgaard H. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? [J]. Epilepsia, 2001, 42 (Suppl 4) : 13- 18.
  • 10Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam [ J ]. Proc Natl Acad Sci USA, 2004, 101 (26) :9861-9866.

引证文献9

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部